Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006
This trend article about Harvard University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
According to a study from the United States, "Gelatin hydrogel microspheres (GHMs) have been reported as novel non-viral vectors for gene or protein delivery (GHM therapy). However, the components of an effective catheter-based delivery strategy for GHM therapy are unknown."
"We evaluated the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.